MoonLake Immunotherapeutics Annual Nonoperating Income (Expense) in USD for 2021

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
MoonLake Immunotherapeutics quarterly/annual Nonoperating Income (Expense) history and growth rate for 2021.
  • MoonLake Immunotherapeutics Nonoperating Income (Expense) for the quarter ending March 31, 2022 was $7.77K, a 56.4% decline year-over-year.
  • MoonLake Immunotherapeutics Nonoperating Income (Expense) for the twelve months ending March 31, 2022 was $17.7K.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $27.7K Jan 1, 2021 Dec 31, 2021 10-K 2022-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.